Product Details
| Product Name:
Otilimab |
CAS No.:
1638332-55-4 |
| Purity:
SDS-PAGE:95% SEC-HPLC:95% |
Supply Ability:
10g |
| Release date:
2025/09/11 |
Product Introduction
Bioactivity
| Name | Otilimab |
| Description | Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF). Otilimab has anti-inflammatory activity, regulates the biological function of GM-CSF by blocking the interaction between GM-CSF and its cell surface receptors, and can be used in studies to treat severe COVID-19 pneumonia. |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | Otilimab | MOR-103 | MOR 103 | GSK-3196165 | GSK3196165 | CSF-1R | CSF1R |
| Inhibitors Related | PLX5622 | Sotuletinib | Tandutinib | AZD7507 | Ki20227 | OSI-930 | Pexidartinib | Nampt-IN-1 | PRN1371 | Edicotinib | Linifanib | Vimseltinib |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:1883545-47-8
$1150.00 / 10mg
-
CAS:179051-05-9
$92.00 / 50mg
-
CAS:769901-96-4
$195.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States